Keyun Qing

Title: Keyun Qing: Innovator in Gene Therapy

Introduction

Keyun Qing is a prominent inventor based in Indianapolis, IN (US). He has made significant contributions to the field of gene therapy, particularly through his research on adeno-associated viruses (AAV). His innovative work has implications for enhancing transgene expression, which is crucial for various therapeutic applications.

Latest Patents

Keyun Qing holds a patent titled "Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression." This invention identifies a protein known as the D-sequence-binding protein (D-BP), which is phosphorylated at tyrosine residues. The research demonstrates that D-BP inhibits AAV-mediated transgene expression in infected cells by blocking the leading strand viral DNA synthesis. Furthermore, it reveals that D-BP is phosphorylated by EGF-R protein tyrosine kinase. The patent also discloses methods for increasing transcription and promoting replication of transgenes based on this discovery.

Career Highlights

Keyun Qing is associated with the Advanced Research & Technology Institute, where he continues to explore innovative solutions in gene therapy. His work has garnered attention for its potential to improve therapeutic outcomes in various medical conditions.

Collaborations

Keyun has collaborated with notable researchers in his field, including Arun Srivastava and Xu-Shan Wang. These collaborations have further enriched his research and contributed to advancements in gene therapy.

Conclusion

Keyun Qing's contributions to the field of gene therapy through his innovative patent and collaborative efforts highlight his role as a leading inventor. His work continues to pave the way for advancements in medical treatments and therapies.